Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

4(57.1%)

Phase 1

1(14.3%)

Phase 4

1(14.3%)

N/A

1(14.3%)

7Total

Phase 2(4)

Phase 1(1)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07224347Active Not Recruiting

Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)

Role: collaborator

NCT01968798Phase 4Unknown

ASPREE Cancer Endpoints Study

Role: collaborator

NCT01038583Unknown

Aspirin in Reducing Events in the Elderly

Role: collaborator

NCT01875094Phase 1Completed

Self-Management in Stroke Survivors

Role: collaborator

NCT00567333Not ApplicableCompleted

Individualized Chiropractic and Integrative Care for Low Back Pain

Role: collaborator

NCT00269321Phase 2Completed

Chiropractic and Exercise for Seniors With Low Back Pain

Role: collaborator

NCT00269308Phase 2Completed

Chiropractic and Exercise for Seniors With Neck Pain

Role: collaborator

NCT00269360Phase 2Completed

Manipulation, Exercise, and Self-Care for Neck Pain

Role: collaborator

NCT00269347Phase 2Completed

Manipulation, Exercise, and Self-Care for Low Back Pain

Role: collaborator

All 9 trials loaded